Navitus Health Solutions

A transparent pharmacy benefit manager (PBM) should make it easy to understand where its revenue comes from. Yet in many traditional models, rebates are retained, spread pricing is used and fees are hidden - all of which increase costs for plan sponsors. At Navitus, we keep it simple: no hidden fees, no retained revenue, no surprises. Just measurable, transparent performance that keeps clients in control of their pharmacy benefits. Think your PBM is truly transparent? Learn how to evaluate it in our latest blog: https://xmrrwallet.com/cmx.pow.ly/QTNO50WuJZG

The increase in costs for specialty drugs underscores the urgent need for your pharmacy benefits plan to manage specialty costs effectively. Discover actionable insights in our 9th annual Drug Trend Report: https://xmrrwallet.com/cmx.pow.ly/BGmy50WtBOm #SpecialtyPharmacy #PharmacyBenefits #DrugTrendReport

Employers in the 5,000 members or less size range are often underserved by their pharmacy benefit manager (PBM). Meanwhile, just one employee with a high-price prescription can make plan costs skyrocket. We offer the Navitus Key solution, specifically designed for this market segment, to help control rising costs with industry-leading programs and high-touch services. Employers who implement our Navitus Key solution receive unmatched PBM expertise, cost-savings and support. Our 2024 client satisfaction survey results highlighted a 100% client satisfaction rate, with post-implementation surveys showing 100% of clients were satisfied with the transition process. Ready to learn more about how our Navitus Key solution could benefit your organization? Visit https://xmrrwallet.com/cmx.pow.ly/27Xr50WsUni.

We’re excited to return to Michigan Association of Health Plans 2025 to share how our transparent, 100% pass-through model is helping Michigan health plans take control of rising drug costs while improving member outcomes. From eliminating spread pricing to giving full visibility into cost, our model is designed to support smarter pharmacy benefit decisions without compromising quality of care. Curious to learn more? Stop by Navitus booth X to connect with our team and join us for a 10-minute session on July 24, at 8:45 a.m. Plus, don’t miss your chance to spin the wheel for our Nintendo® Switch™ 2 + Mario Kart™ World bundle giveaway! #MAHP2025

Prescription drug spending rose by 11.4% in 2024 — and that growth isn’t slowing down. For decision-makers, understanding what’s driving this trend is more important than ever. Join Navitus clinical experts, Ryan Schmidt, PharmD, and Imke Scheepers, PharmD, on Tuesday, July 29, at 3:00 p.m. EST, for a live webinar exploring key findings from our 2024 Drug Trend Report. They will share timely insights into current drug cost and utilization trend drivers, the growing role of biosimilars, GLP-1 coverage strategies and the evolving specialty dermatology landscape. Secure your spot and register today to stay ahead of the emerging trends: https://xmrrwallet.com/cmx.pow.ly/XT3N50WqQmz

In recent years, “transparency” has become one of the most overused terms in the pharmacy benefit management (PBM) industry. It sounds good, but too often, it’s left undefined or used as a placeholder for promises that don’t hold up under scrutiny. Some PBMs offer partial transparency, leaving hidden revenue streams or vague contract terms in place. For plan sponsors and consultants, this raises an important question: How can you tell if your PBM’s version of transparency delivers its promises? Learn how you can evaluate whether your PBM is truly transparent — or just checking a box — in our latest blog: https://xmrrwallet.com/cmx.pow.ly/Ylpa50WqzMn.

The release of our 9th annual Drug Trend Report provides critical insights into the key categories driving pharmaceutical spend. Stay informed and optimize your pharmacy benefit strategies by accessing the full report at: https://xmrrwallet.com/cmx.pow.ly/Al9Y50Wq937. #DrugTrendReport #HealthcareCosts #EmployeeBenefits

Rising drug spending isn’t just a headline — it’s a reality shaping the pharmacy benefit management industry. To help decision-makers understand what's driving these costs, Navitus is hosting a live webinar on Tuesday, July 29 at 3:00 p.m. EST. Join our clinical experts, Ryan Schmidt, PharmD, and Imke Scheepers, PharmD, as they explore three of the most impactful cost and utilization trends from our 2024 Drug Trend Report. Topics will include: ▪️Impact of biosimilars on the targeted immunomodulators (TIMs) category ▪️GLP-1 coverage strategies and their effects on plan design and member behavior ▪️New therapies and expanded indications in the dermatology landscape Don’t miss this opportunity to gain valuable insights that can support smarter benefit decisions. Register today: https://xmrrwallet.com/cmx.pow.ly/hzAn50WomxU

Please join us in welcoming our newest PGY-1 Managed Care residents: Alan Albrecht, PharmD; Marium Mesia, PharmD; Scott Weber, PharmD; and Neha Seella, PharmD. The Navitus PGY1 Managed Care Residency Program is accredited by the American Society of Health-System Pharmacists (ASHP) in partnership with the Academy of Managed Care Pharmacy (AMCP). To learn more about our program, visit: https://xmrrwallet.com/cmx.pow.ly/2S5t50WjlAq

We are hiring a Sr. Proposal Analyst! This role plays a key part in supporting client acquisition and retention by creating strategic, persuasive and high-quality responses to RFPs and other sales-related documents. We’re looking for a strong writer and project manager with at least four years of proposal experience — ideally in a health care or PBM environment. If you're ready to join a team committed to improving health care access and patient outcomes, apply here: https://xmrrwallet.com/cmx.pow.ly/caO450WjjGf For your security, please note that upon submitting an application, all recruitment communications will come from an email domain of @navitus.com. #Hiring #RemoteJobs